Agenus reported $18.95M in Loan Capital for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
Acceleron Pharma XLRN:US $ 0M 0M
Amgen AMGN:US $ 33291M 4833M
AstraZeneca AZN:LN 28939M 4338M
Bristol Myers Squibb BMY:US $ 39677M 2826M
Celldex Therapeutics CLDX:US $ 0M 0M
Chemocentryx CCXI:US $ 9.56M 2.01M
CSL CSL:AU $ 5.33B 347.1M
Dicerna Pharmaceuticals DRNA:US $ 0M 0M
Eli Lilly And LLY:US $ 15522.4M 785.8M
Flexion Therapeutics FLXN:US $ 250.5M 30.48M
Genocea Biosciences GNCA:US $ 5.33M 1.17M
GlaxoSmithKline GSK:LN 20736M 294M
Glaxosmithkline GSK:US $ 20736M 294M
Jiangsu Hengrui Me. 600276:CH CH 49.97M 1.82M
Karyopharm Therapeutics KPTI:US $ 301.57M 195K
Macrogenics MGNX:US $ 0 0
Merck MRK:GR € 8195M 526M
Northwest Biotherapeutics NWBO:US 12.34M 53K
Novartis NOVN:VX SF 24715M 1776M
Novavax NVAX:US $ 323.1M 8.84M
Regeneron Pharmaceuticals REGN:US $ 1979.6M 0.4M
Rigel Pharmaceuticals RIGL:US $ 19.89M 0.03M
Sangamo Biosciences SGMO:US $ 0M 0M
Veracyte VCYT:US $ 1.08M 0.16M
YTE INCY:US $ 31.38M 0.46M